Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 463

1.

RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.

Dobaño C, Ubillos I, Jairoce C, Gyan B, Vidal M, Jiménez A, Santano R, Dosoo D, Nhabomba AJ, Ayestaran A, Aguilar R, Williams NA, Díez-Padrisa N, Lanar D, Chauhan V, Chitnis C, Dutta S, Gaur D, Angov E, Asante KP, Owusu-Agyei S, Valim C, Gamain B, Coppel RL, Cavanagh D, Beeson JG, Campo JJ, Moncunill G.

BMC Med. 2019 Aug 14;17(1):157. doi: 10.1186/s12916-019-1378-6.

2.

Differential Patterns of IgG Subclass Responses to Plasmodium falciparum Antigens in Relation to Malaria Protection and RTS,S Vaccination.

Dobaño C, Santano R, Vidal M, Jiménez A, Jairoce C, Ubillos I, Dosoo D, Aguilar R, Williams NA, Díez-Padrisa N, Ayestaran A, Valim C, Asante KP, Owusu-Agyei S, Lanar D, Chauhan V, Chitnis C, Dutta S, Angov E, Gamain B, Coppel RL, Beeson JG, Reiling L, Gaur D, Cavanagh D, Gyan B, Nhabomba AJ, Campo JJ, Moncunill G.

Front Immunol. 2019 Mar 15;10:439. doi: 10.3389/fimmu.2019.00439. eCollection 2019.

3.

Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1-4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies.

Ubillos I, Jiménez A, Vidal M, Bowyer PW, Gaur D, Dutta S, Gamain B, Coppel R, Chauhan V, Lanar D, Chitnis C, Angov E, Beeson J, Cavanagh D, Campo JJ, Aguilar R, Dobaño C.

Malar J. 2018 Jun 1;17(1):219. doi: 10.1186/s12936-018-2369-3.

4.

Antibody responses to P. falciparum blood stage antigens and incidence of clinical malaria in children living in endemic area in Burkina Faso.

Cherif MK, Ouédraogo O, Sanou GS, Diarra A, Ouédraogo A, Tiono A, Cavanagh DR, Michael T, Konaté AT, Watson NL, Sanza M, Dube TJT, Sirima SB, Nebié I.

BMC Res Notes. 2017 Sep 8;10(1):472. doi: 10.1186/s13104-017-2772-9.

5.

Epilepsy and Pregnancy: For healthy pregnancies and happy outcomes. Suggestions for service improvements from the Multispecialty UK Epilepsy Mortality Group.

Leach JP, Smith PE, Craig J, Bagary M, Cavanagh D, Duncan S, Kelso ARC, Marson AG, McCorry D, Nashef L, Nelson-Piercy C, Northridge R, Sieradzan K, Thangaratinam S, Walker M, Winterbottom J, Reuber M.

Seizure. 2017 Aug;50:67-72. doi: 10.1016/j.seizure.2017.05.004. Epub 2017 Jun 1. Review.

6.

Seroepidemiology of Plasmodium species infections in Zimbabwean population.

Amanfo SA, Mduluza T, Midzi N, Cavanagh DR, Mutapi F.

Malar J. 2016 May 10;15(1):267. doi: 10.1186/s12936-016-1325-3.

7.

Draft Genome Sequence of Lactobacillus casei DPC6800, an Isolate with the Potential to Diversify Flavor in Cheese.

Stefanovic E, Casey A, Cotter P, Cavanagh D, Fitzgerald G, McAuliffe O.

Genome Announc. 2016 Mar 3;4(2). pii: e00063-16. doi: 10.1128/genomeA.00063-16.

8.

Antibody levels against GLURP R2, MSP1 block 2 hybrid and AS202.11 and the risk of malaria in children living in hyperendemic (Burkina Faso) and hypo-endemic (Ghana) areas.

Adu B, Cherif MK, Bosomprah S, Diarra A, Arthur FK, Dickson EK, Corradin G, Cavanagh DR, Theisen M, Sirima SB, Nebie I, Dodoo D.

Malar J. 2016 Feb 27;15:123. doi: 10.1186/s12936-016-1146-4.

9.

The early immune response to infection of chickens with Infectious Bronchitis Virus (IBV) in susceptible and resistant birds.

Smith J, Sadeyen JR, Cavanagh D, Kaiser P, Burt DW.

BMC Vet Res. 2015 Oct 9;11:256. doi: 10.1186/s12917-015-0575-6.

10.

Blood Interferon Signatures Putatively Link Lack of Protection Conferred by the RTS,S Recombinant Malaria Vaccine to an Antigen-specific IgE Response.

Rinchai D, Presnell S, Vidal M, Dutta S, Chauhan V, Cavanagh D, Moncunill G, Dobaño C, Chaussabel D.

Version 2. F1000Res. 2015 Sep 29 [revised 2017 Jan 1];4:919. doi: 10.12688/f1000research.7093.2. eCollection 2015.

11.

α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes.

Stevenson L, Laursen E, Cowan GJ, Bandoh B, Barfod L, Cavanagh DR, Andersen GR, Hviid L.

PLoS Pathog. 2015 Jul 2;11(7):e1005022. doi: 10.1371/journal.ppat.1005022. eCollection 2015 Jul.

12.

Evaluation of Lactococcus lactis Isolates from Nondairy Sources with Potential Dairy Applications Reveals Extensive Phenotype-Genotype Disparity and Implications for a Revised Species.

Cavanagh D, Casey A, Altermann E, Cotter PD, Fitzgerald GF, McAuliffe O.

Appl Environ Microbiol. 2015 Jun 15;81(12):3961-72. doi: 10.1128/AEM.04092-14. Epub 2015 Apr 3.

13.

From field to fermentation: the origins of Lactococcus lactis and its domestication to the dairy environment.

Cavanagh D, Fitzgerald GF, McAuliffe O.

Food Microbiol. 2015 May;47:45-61. doi: 10.1016/j.fm.2014.11.001. Epub 2014 Nov 11. Review.

PMID:
25583337
14.

Enhancing midwives' scope of practice: an innovative educational program for delivery suite operating rooms.

Brown JA, Dunning CF, Cavanagh D, Cross LA.

J Contin Educ Nurs. 2015 Feb;46(2):89-96. doi: 10.3928/00220124-20151217-04. Epub 2014 Dec 17.

PMID:
25522377
15.

Antibody and T-cell responses associated with experimental human malaria infection or vaccination show limited relationships.

Walker KM, Okitsu S, Porter DW, Duncan C, Amacker M, Pluschke G, Cavanagh DR, Hill AV, Todryk SM.

Immunology. 2015 May;145(1):71-81. doi: 10.1111/imm.12428.

16.

Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophy.

Meinke P, Schneiderat P, Srsen V, Korfali N, Lê Thành P, Cowan GJ, Cavanagh DR, Wehnert M, Schirmer EC, Walter MC.

Neuromuscul Disord. 2015 Feb;25(2):127-36. doi: 10.1016/j.nmd.2014.09.012. Epub 2014 Oct 6.

17.

Is Fc gamma receptor IIA (FcγRIIA) polymorphism associated with clinical malaria and Plasmodium falciparum specific antibody levels in children from Burkina Faso?

Cherif MK, Sanou GS, Bougouma EC, Diarra A, Ouédraogo A, Dolo A, Troye-Blomberg M, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Acta Trop. 2015 Feb;142:41-6. doi: 10.1016/j.actatropica.2014.09.019. Epub 2014 Oct 31.

PMID:
25447268
18.

A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila.

Cowan GJ, Bockau U, Eleni-Muus J, Aldag I, Samuel K, Creasey AM, Hartmann MW, Cavanagh DR.

PLoS One. 2014 Jan 29;9(1):e87198. doi: 10.1371/journal.pone.0087198. eCollection 2014.

19.

Phages of non-dairy lactococci: isolation and characterization of ΦL47, a phage infecting the grass isolate Lactococcus lactis ssp. cremoris DPC6860.

Cavanagh D, Guinane CM, Neve H, Coffey A, Ross RP, Fitzgerald GF, McAuliffe O.

Front Microbiol. 2014 Jan 13;4:417. doi: 10.3389/fmicb.2013.00417. eCollection 2014 Jan 13.

20.

Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.

Cavanagh DR, Kocken CH, White JH, Cowan GJ, Samuel K, Dubbeld MA, Voorberg-van der Wel A, Thomas AW, McBride JS, Arnot DE.

PLoS One. 2014 Jan 8;9(1):e83704. doi: 10.1371/journal.pone.0083704. eCollection 2014.

21.

Immunological consequences of antihelminthic treatment in preschool children exposed to urogenital schistosome infection.

Rujeni N, Nausch N, Midzi N, Cowan GJ, Burchmore R, Cavanagh DR, Taylor DW, Mduluza T, Mutapi F.

J Trop Med. 2013;2013:283619. doi: 10.1155/2013/283619. Epub 2013 Jun 5.

22.

Diversity covering AMA1-MSP119 fusion proteins as malaria vaccines.

Faber BW, Younis S, Remarque EJ, Rodriguez Garcia R, Riasat V, Walraven V, van der Werff N, van der Eijk M, Cavanagh DR, Holder AA, Thomas AW, Kocken CH.

Infect Immun. 2013 May;81(5):1479-90. doi: 10.1128/IAI.01267-12. Epub 2013 Feb 19.

23.

Development and evaluation of a multiplex screening assay for Plasmodium falciparum exposure.

Jepsen MP, Röser D, Christiansen M, Olesen Larsen S, Cavanagh DR, Dhanasarnsombut K, Bygbjerg I, Dodoo D, Remarque EJ, Dziegiel M, Jepsen S, Mordmüller B, Theisen M.

J Immunol Methods. 2012 Oct 31;384(1-2):62-70. doi: 10.1016/j.jim.2012.07.009. Epub 2012 Jul 23.

PMID:
22835432
24.

FcγRIIa polymorphism and anti-malaria-specific IgG and IgG subclass responses in populations differing in susceptibility to malaria in Burkina Faso.

Cherif MK, Sanou GS, Maiga B, Israelsson E, Ouédraogo AL, Bougouma EC, Diarra A, Ouédraogo A, Ouattara AS, Troye-Blomberg M, Dolo A, Cavanagh DR, Theisen M, Modiano D, Sirima SB, Nebié I.

Scand J Immunol. 2012 Jun;75(6):606-13. doi: 10.1111/j.1365-3083.2012.02690.x.

25.

Plasmodium falciparum 19-kilodalton merozoite surface protein 1 (MSP1)-specific antibodies that interfere with parasite growth in vitro can inhibit MSP1 processing, merozoite invasion, and intracellular parasite development.

Moss DK, Remarque EJ, Faber BW, Cavanagh DR, Arnot DE, Thomas AW, Holder AA.

Infect Immun. 2012 Mar;80(3):1280-7. doi: 10.1128/IAI.05887-11. Epub 2011 Dec 27.

26.

Modification of the avian coronavirus infectious bronchitis virus for vaccine development.

Britton P, Armesto M, Cavanagh D, Keep S.

Bioeng Bugs. 2012 Mar-Apr;3(2):114-9. doi: 10.4161/bbug.18983. Epub 2012 Mar 1.

27.

A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.

Cowan GJ, Creasey AM, Dhanasarnsombut K, Thomas AW, Remarque EJ, Cavanagh DR.

PLoS One. 2011;6(10):e26616. doi: 10.1371/journal.pone.0026616. Epub 2011 Oct 26.

28.

A recombinant avian infectious bronchitis virus expressing a heterologous spike gene belonging to the 4/91 serotype.

Armesto M, Evans S, Cavanagh D, Abu-Median AB, Keep S, Britton P.

PLoS One. 2011;6(8):e24352. doi: 10.1371/journal.pone.0024352. Epub 2011 Aug 30.

29.

Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria.

Imai N, Rujeni N, Nausch N, Bourke CD, Appleby LJ, Cowan G, Gwisai R, Midzi N, Cavanagh D, Mduluza T, Taylor D, Mutapi F.

Parasitology. 2011 Oct;138(12):1519-33. doi: 10.1017/S0031182011001181. Epub 2011 Aug 4.

30.

Screening trematodes for novel intervention targets: a proteomic and immunological comparison of Schistosoma haematobium, Schistosoma bovis and Echinostoma caproni.

Higón M, Cowan G, Nausch N, Cavanagh D, Oleaga A, Toledo R, Stothard JR, Antúnez O, Marcilla A, Burchmore R, Mutapi F.

Parasitology. 2011 Oct;138(12):1607-19. doi: 10.1017/S0031182011000412. Epub 2011 Jun 10.

31.

Towards validated assays for key immunological outcomes in malaria vaccine development.

OPTIMALVAC consortium, Cavanagh DR, Dubois PM, Holtel A, Kisser A, Leroy O, Locke E, Moorthy VS, Remarque EJ, Shi YP.

Vaccine. 2011 Apr 12;29(17):3093-5. doi: 10.1016/j.vaccine.2011.01.070. Epub 2011 Feb 4. No abstract available.

32.

Clinical and microbiological characteristics of fungal keratitis in the United States, 2001-2007: a multicenter study.

Keay LJ, Gower EW, Iovieno A, Oechsler RA, Alfonso EC, Matoba A, Colby K, Tuli SS, Hammersmith K, Cavanagh D, Lee SM, Irvine J, Stulting RD, Mauger TF, Schein OD.

Ophthalmology. 2011 May;118(5):920-6. doi: 10.1016/j.ophtha.2010.09.011. Epub 2011 Feb 4.

33.

Facial reconstruction: soft tissue thickness values for South African black females.

Cavanagh D, Steyn M.

Forensic Sci Int. 2011 Mar 20;206(1-3):215.e1-7. doi: 10.1016/j.forsciint.2011.01.009. Epub 2011 Feb 1.

PMID:
21288672
34.

The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity.

Armesto M, Cavanagh D, Britton P.

PLoS One. 2009 Oct 9;4(10):e7384. doi: 10.1371/journal.pone.0007384.

35.

The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.

Gumus K, Cavanagh DH.

Clin Ophthalmol. 2009;3:57-67. Epub 2009 Jun 2.

36.

The precautionary principle: what is the risk of reusing disposable drops in routine ophthalmology consultations and what are the costs of reducing this risk to zero?

Somner JE, Cavanagh DJ, Wong KK, Whitelaw M, Thomson T, Mansfield D.

Eye (Lond). 2010 Feb;24(2):361-3. doi: 10.1038/eye.2009.129. Epub 2009 Jun 12.

PMID:
19521427
37.

Changes to the editorial team.

Cavanagh D.

Avian Pathol. 2009 Jun;38(3):191. doi: 10.1080/03079450902914958. No abstract available.

PMID:
19468934
38.

SARS- and other coronaviruses.

Cavanagh D.

Methods Mol Biol. 2008;454:v-vi. No abstract available.

PMID:
19068525
39.

Transient dominant selection for the modification and generation of recombinant infectious bronchitis coronaviruses.

Armesto M, Casais R, Cavanagh D, Britton P.

Methods Mol Biol. 2008;454:255-73. doi: 10.1007/978-1-59745-181-9_19.

PMID:
19057872
40.

RT-PCR detection of avian coronaviruses of galliform birds (chicken, turkey, pheasant) and in a parrot.

Culver FA, Britton P, Cavanagh D.

Methods Mol Biol. 2008;454:35-42. doi: 10.1007/978-1-59745-181-9_4.

PMID:
19057865
41.

Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.

Reilly L, Magkrioti C, Mduluza T, Cavanagh DR, Mutapi F.

BMC Infect Dis. 2008 Nov 17;8:158. doi: 10.1186/1471-2334-8-158.

42.

Influenza virosomes: a flu jab for malaria?

Cavanagh DR, Remarque EJ, Sauerwein RW, Hermsen CC, Luty AJ.

Trends Parasitol. 2008 Sep;24(9):382-5. doi: 10.1016/j.pt.2008.06.002. Epub 2008 Aug 5.

PMID:
18684667
43.

Comparative testing of six antigen-based malaria vaccine candidates directed toward merozoite-stage Plasmodium falciparum.

Arnot DE, Cavanagh DR, Remarque EJ, Creasey AM, Sowa MP, Morgan WD, Holder AA, Longacre S, Thomas AW.

Clin Vaccine Immunol. 2008 Sep;15(9):1345-55. doi: 10.1128/CVI.00172-08. Epub 2008 Jun 11.

44.

Changes to Avian Pathology, including an increase to six issues per year.

Cavanagh D.

Avian Pathol. 1998;27(1):6. doi: 10.1080/03079459808419267. No abstract available.

PMID:
18483958
45.

Molecular analysis of the 793/B serotype of infectious bronchitis virus in Great Britain.

Adzhar A, Gough RE, Haydon D, Shaw K, Britton P, Cavanagh D.

Avian Pathol. 1997;26(3):625-40. doi: 10.1080/03079459708419239.

PMID:
18483932
46.

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Osier FH, Fegan G, Polley SD, Murungi L, Verra F, Tetteh KK, Lowe B, Mwangi T, Bull PC, Thomas AW, Cavanagh DR, McBride JS, Lanar DE, Mackinnon MJ, Conway DJ, Marsh K.

Infect Immun. 2008 May;76(5):2240-8. doi: 10.1128/IAI.01585-07. Epub 2008 Mar 3.

47.

Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria.

Dobaño C, Rogerson SJ, Mackinnon MJ, Cavanagh DR, Taylor TE, Molyneux ME, McBride JS.

J Infect Dis. 2008 Mar 1;197(5):766-74. doi: 10.1086/527490.

PMID:
18260767
48.

A recombinant turkey herpesvirus expressing chicken interleukin-2 increases the protection provided by in ovo vaccination with infectious bursal disease and infectious bronchitis virus.

Tarpey I, van Loon AA, de Haas N, Davis PJ, Orbell S, Cavanagh D, Britton P, Casais R, Sondermeijer P, Sundick R.

Vaccine. 2007 Dec 12;25(51):8529-35. Epub 2007 Oct 24.

PMID:
17996994
49.

Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins.

Cavanagh D, Casais R, Armesto M, Hodgson T, Izadkhasti S, Davies M, Lin F, Tarpey I, Britton P.

Vaccine. 2007 Jul 26;25(30):5558-62. Epub 2007 Mar 6.

PMID:
17416443
50.

Coronavirus avian infectious bronchitis virus.

Cavanagh D.

Vet Res. 2007 Mar-Apr;38(2):281-97. Epub 2007 Feb 13. Review.

Supplemental Content

Loading ...
Support Center